BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6412290)

  • 21. Varicella as a trigger of atypical haemolytic uraemic syndrome associated with complement dysfunction: two cases.
    Kwon T; Belot A; Ranchin B; Baudouin V; Fremeaux-Bacchi V; Dragon-Durey MA; Cochat P; Loirat C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2752-4. PubMed ID: 19376828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postpartum hemolytic-uremic syndrome associated with lupus anticoagulant. A case report.
    Gherman RB; Tramont J; Connito DJ
    J Reprod Med; 1999 May; 44(5):471-4. PubMed ID: 10360263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemolytic uremic syndrome in childhood: study of several factors potentially related with its genesis].
    Olavarría F; Mezzano S; Reinoso S; Delucchi A; Prado V
    Rev Med Chil; 1994 Jan; 122(1):36-41. PubMed ID: 8066341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "New" lectins for the identification of erythrocyte cryptantigens and the classification of erythrocyte polyagglutinability: Medicago disciformis and Medicago turbinata.
    Bird GW; Wingham J
    J Clin Pathol; 1983 Feb; 36(2):195-6. PubMed ID: 6826775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glomerular epithelial cell arachidonate metabolism in Shiga toxin hemolytic uremic syndrome.
    Kaplan BS; Meyers KE; Leonard MB
    Kidney Int; 2001 Sep; 60(3):1199-200. PubMed ID: 11532117
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization and quantification of anti-T in human serum using a reliable hemolysis test.
    Lynen R; Simson G; Rumpf KW; Neumeyer H
    Vox Sang; 1991; 61(4):258-64. PubMed ID: 1776243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemolytic uremic syndrome after Campylobacter-induced diarrhea in an adult.
    Delans RJ; Biuso JD; Saba SR; Ramirez G
    Arch Intern Med; 1984 May; 144(5):1074-6. PubMed ID: 6712399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.
    Marmont AM; Gualandi F; Occhini D; Morandi F; Ferretti E; Pezzolo A; Strada P; Ravetti JL; Pistoia V; Falanga A; Bacigalupo A
    Autoimmunity; 2006 Sep; 39(6):505-11. PubMed ID: 17060030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
    Louise CB; Obrig TG
    Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathogenic aspects of the hemolytic-uremic syndrome. (The toxic effect of neuraminidase)].
    Janda J; Spicáková V; Kout M
    Cesk Pediatr; 1981 Feb; 36(2):83-5. PubMed ID: 7471300
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemolytic-uremic syndrome in the adult (author's transl)].
    Montoliu J; Darnell A; Torras A; Botey A; Revert L
    Med Clin (Barc); 1980 Jan; 74(1):5-10. PubMed ID: 7351870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on evaluating complement in hemolytic uremic syndrome.
    Kavanagh D; Goodship TH
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):565-71. PubMed ID: 18089972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verocytotoxigenic Escherichia coli serologic responses in patients with hemolytic uremic syndrome.
    Goldwater PN; Bettelheim KA
    J Infect Dis; 2002 Aug; 186(4):582; author reply 582-3. PubMed ID: 12195391
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hemolytic-uremic syndrome in pneumococcal meningitis and infection. Importance of T-transformation].
    Eber SW; Polster H; Quentin SH; Rumpf KW; Lynen R
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):219-22. PubMed ID: 8474469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemolytic-uremic syndrome, low C-3 and positive ANCA].
    Castellano I; Pereira LF; Gómez-Martino JR; Covarsí A
    Nefrologia; 2006; 26(1):146-7. PubMed ID: 16649441
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Franchini M; Zaffanello M; Veneri D
    Thromb Res; 2006; 118(2):177-84. PubMed ID: 16126255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephron injury in the haemolytic-uraemic syndrome complicating bacillary dysentery.
    Date A; Raghupathy P; Shastry JC
    J Pathol; 1981 Jan; 133(1):1-16. PubMed ID: 7205438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of defective complement control in hemolytic uremic syndrome.
    Zipfel PF; Misselwitz J; Licht C; Skerka C
    Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathomorphology of the kidneys in hemolytic-uremic syndrome in children].
    Khodasevich LS; Perov IuL; Nazhimov VP
    Arkh Patol; 1997; 59(3):38-44. PubMed ID: 9290024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of I and i antigen receptors on the membrane of erythrocytes in sickle cell anemia.
    Basu MK; Lee MM; Maniatis A; Bertles JF
    J Lab Clin Med; 1984 May; 103(5):712-9. PubMed ID: 6715951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.